New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions
AbstractIt also indicates greater Agency scrutiny of such transactions in industries characterized by differentiated products and high levels of R&D spendingÃ¢â‚¬â€such as the high tech and pharmaceutical industries. Janet McDavid & Eric Stock (Hogan Lovells)
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Competition Policy International in its journal CPI Journal OCT-10(2).
Volume (Year): 10 (2010)
Issue (Month): ()
Contact details of provider:
Web page: https://www.competitionpolicyinternational.com
Find related papers by JEL classification:
- G34 - Financial Economics - - Corporate Finance and Governance - - - Mergers; Acquisitions; Restructuring; Corporate Governance
- G38 - Financial Economics - - Corporate Finance and Governance - - - Government Policy and Regulation
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Lindsay McSweeney).
If references are entirely missing, you can add them using this form.